IL7 and cancer: Therefore, elevated plasmatic IL-7 may sustain the increased distribution of CD127lo CCR7−CD45RA−CD8+ T cell and CCR7−CD45RA+CD8+ T cell subsets in the circulation of cancer patients or may be due to that CCR7−CD45RA+CD8+ T cell subsets consumed less IL-7.